Hansa Medical appoints Sam Agus as new Chief Medical Officer
Hansa Medical AB (publ), a biopharmaceutical company developing novel immunomodulatory enzymes, announced today the recruitment of Sam Agus, MD, as Chief Medical Officer.Sam Agus has a broad experience from the pharmaceutical industry and was most recently Chief Specialist, Medical Affairs Neurology at H. Lundbeck A/S. He has previously held various leading positions at several pharmaceutical companies, including Shire, Solvay Pharmaceuticals and Abbott Laboratories. He is a board-certified neurologist and has extensive experience in medical strategy, multidisciplinary team leadership,